3,286
Views
9
CrossRef citations to date
0
Altmetric
Nephrology

Worsening of kidney function in patients with atrial fibrillation and chronic kidney disease: evidence from the real-world CALLIPER study

, ORCID Icon, , &
Pages 937-945 | Received 31 Aug 2021, Accepted 30 Mar 2022, Published online: 22 Apr 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jelena Simic, Miroslav Mihajlovic, Nevena Zec, Vladan Kovacevic, Milan Marinkovic, Nebojsa Mujovic & Tatjana Potpara. (2023) The impact of anticoagulation therapy on kidney function in patients with atrial fibrillation and chronic kidney disease. Expert Review of Cardiovascular Therapy 21:12, pages 937-945.
Read now
Yusen Zhao, Bing Luo, Zhimin Zhang, Yanfei Wang, Yujiao Zhang, Ru Zhao, Zhenshun Hu, Yuexiang Zhu, Shujun Cui & Haiyan Meng. (2023) Comparison of value of 640-slice CT kidney scan and kidney ultrasound in the diagnosis of chronic kidney disease. Biotechnology and Genetic Engineering Reviews 0:0, pages 1-13.
Read now

Articles from other publishers (7)

Panteleimon E. Papakonstantinou, Vasiliki Kalogera, Dimitrios Charitos, Dimitrios Polyzos, Dimitra Benia, Athina Batsouli, Konstantinos Lampropoulos, Sotirios Xydonas, Dhiraj Gupta & Gregory Y.H. Lip. (2024) When anticoagulation management in atrial fibrillation becomes difficult: Focus on chronic kidney disease, coagulation disorders, and cancer. Blood Reviews 65, pages 101171.
Crossref
Vincent Brandenburg & Gunnar Henrik Heine. (2024) Antikoagulation bei abnormer Nierenfunktion oder Dialyse. Nephrologie aktuell 28:03, pages 132-138.
Crossref
A.E. Baylo, V.V. Cherniavskyi, L.S. Hvozdetska, V.V. Tishchenko & D.O. Reshotko. (2023) Assessment and comparative analysis of renal function parameters in patients with liver cirrhosis and atrial fibrillation. GASTROENTEROLOGY 57:4, pages 201-207.
Crossref
Peiyi Yin, Yongbin Wu, Xiang Long, Shuqiang Zhu, Shiwei Chen, Feng Lu, Kun Lin & Jianjun Xu. (2023) HACE1 expression in heart failure patients might promote mitochondrial oxidative stress and ferroptosis by targeting NRF2. Aging 15:23, pages 13888-13900.
Crossref
Minh That Ton, Tri Huynh Quang Ho, Viet Lan Nguyen, Hung Manh Pham, Sy Van Hoang, Nhan Thanh Vo, Thai Quoc Nguyen, Linh Tran Pham, Ton Duy Mai & Thang Huy Nguyen. (2023) Selection of Non-vitamin K Antagonist Oral Anticoagulant for Stroke Prevention in Atrial Fibrillation Based on Patient Profile: Perspectives from Vietnamese Experts. Part 2. European Cardiology Review 18.
Crossref
A. G. Komarova, N. L. Lyakhova, S. D. Covantsev, E. A. Naryshkina & D. V. Slepukhova. (2023) Anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: Arguments for or against. Medical alphabet:25, pages 14-20.
Crossref
Kathrine Parker, John Hartemink, Ananya Saha, Roshni Mitra, Penny Lewis, Albert Power, Satarupa Choudhuri, Sandip Mitra & Jecko Thachil. (2022) A systematic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease. Journal of Nephrology 35:8, pages 2015-2033.
Crossref